Robert Philibert
Directeur Technique/Scientifique/R&D chez CARDIO DIAGNOSTICS HOLDINGS, INC.
Fortune : 1 M $ au 30/04/2024
Profil
Robert Philibert is the founder of Behavioral Diagnostics, LLC (founded in 2009) and Cardio Diagnostics, Inc. (founded in 2017).
He is currently the Chief Medical Officer & Director at Cardio Diagnostics Holdings, Inc. (since 2022) and a Professor at the University of Iowa (since 1998).
He completed his undergraduate degree at the University of Iowa.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
01/04/2024 | 1 649 792 ( 7,64% ) | 1 M $ | 30/04/2024 |
Postes actifs de Robert Philibert
Sociétés | Poste | Début |
---|---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 25/10/2022 |
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Fondateur | 01/05/2017 |
University of Iowa | Corporate Officer/Principal | 01/01/1998 |
Anciens postes connus de Robert Philibert
Sociétés | Poste | Fin |
---|---|---|
Behavioral Diagnostics, LLC | Fondateur | - |
Formation de Robert Philibert
University of Iowa | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
Behavioral Diagnostics, LLC |